133 related articles for article (PubMed ID: 16049550)
1. A tubule cell model for ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
Can J Physiol Pharmacol; 2005 Jun; 83(6):499-508. PubMed ID: 16049550
[TBL] [Abstract][Full Text] [Related]
2. Renal ontogeny of ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
J Lab Clin Med; 2004 Dec; 144(6):285-93. PubMed ID: 15614250
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity.
Aleksa K; Matsell D; Krausz K; Gelboin H; Ito S; Koren G
Pediatr Nephrol; 2005 Jul; 20(7):872-85. PubMed ID: 15875221
[TBL] [Abstract][Full Text] [Related]
4. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.
Woodland C; Ito S; Granvil CP; Wainer IW; Klein J; Koren G
Life Sci; 2000 Nov; 68(1):109-17. PubMed ID: 11132240
[TBL] [Abstract][Full Text] [Related]
5. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
Chen N; Aleksa K; Woodland C; Rieder M; Koren G
Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective metabolism of ifosfamide by the kidney.
Aleksa K; Ito S; Koren G
Chirality; 2006 Jun; 18(6):398-405. PubMed ID: 16575879
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
8. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
Storme T; Deroussent A; Mercier L; Prost E; Re M; Munier F; Martens T; Bourget P; Vassal G; Royer J; Paci A
J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
[TBL] [Abstract][Full Text] [Related]
9. Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.
Aleksa K; Ito S; Koren G
J Lab Clin Med; 2004 Mar; 143(3):159-62. PubMed ID: 15007305
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.
Gunness P; Aleksa K; Kosuge K; Ito S; Koren G
Can J Physiol Pharmacol; 2010 Apr; 88(4):448-55. PubMed ID: 20555413
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Arch Toxicol; 2008 Sep; 82(9):607-14. PubMed ID: 18214444
[TBL] [Abstract][Full Text] [Related]
12. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip.
Choucha-Snouber L; Aninat C; Grsicom L; Madalinski G; Brochot C; Poleni PE; Razan F; Guillouzo CG; Legallais C; Corlu A; Leclerc E
Biotechnol Bioeng; 2013 Feb; 110(2):597-608. PubMed ID: 22887128
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide toxicity in cultured proximal renal tubule cells.
Springate J; Taub M
Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
[TBL] [Abstract][Full Text] [Related]
14. Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells.
Valente MJ; Henrique R; Vilas-Boas V; Silva R; Bastos Mde L; Carvalho F; Guedes de Pinho P; Carvalho M
Arch Toxicol; 2012 Feb; 86(2):249-61. PubMed ID: 21983858
[TBL] [Abstract][Full Text] [Related]
15. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS.
Aleksa K; Nava-Ocampo A; Koren G
Chirality; 2009 Jul; 21(7):674-80. PubMed ID: 18825700
[TBL] [Abstract][Full Text] [Related]
17. Renal clearance of ifosfamide.
Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
Chen CS; Jounaidi Y; Waxman DJ
Drug Metab Dispos; 2005 Sep; 33(9):1261-7. PubMed ID: 15919850
[TBL] [Abstract][Full Text] [Related]
19. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.
Roy P; Yu LJ; Crespi CL; Waxman DJ
Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]